Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PDD vs GSK✓SelectedUSD · GSKPDD vs GSK performance historyLatest closeAs of-1.09%11/16
Stock and ETF performance explorer

PDD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+192.5%
GSK return
+84.2%
Excess return
+108.3%
Maximum drawdown
-87.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.1%-0.1%-1.0%-1.1%
7D-3.0%-1.3%-1.7%-2.6%
30D-3.5%+2.7%-6.3%-4.4%
3M-7.9%+2.7%-10.6%-8.8%
6M-18.5%+3.3%-21.8%-19.9%
YTD-31.1%+6.5%-37.6%-33.2%
1Y-40.4%+10.7%-51.0%-43.0%
3Y-30.9%+64.4%-95.3%-44.5%
5Y-16.9%+46.7%-63.6%-30.6%
All+192.5%+84.2%+108.3%+130.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling